-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RFyMnfX05Vf1n44xHxjwxpTSH7m0uZ7P5wFZyxAlBk+Yb8q3zgV21HM2f4WpztrD 0kyJwEK/uhhoxVR0Jb2z7w== 0001127602-09-001052.txt : 20090112 0001127602-09-001052.hdr.sgml : 20090112 20090112184603 ACCESSION NUMBER: 0001127602-09-001052 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081203 FILED AS OF DATE: 20090112 DATE AS OF CHANGE: 20090112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONANNI FABRIZIO CENTRAL INDEX KEY: 0001183903 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 09522592 MAIL ADDRESS: STREET 1: AMGEN INC STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 BUSINESS PHONE: 805-447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE STREET 2: MAIL STOP 27-3-C CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4/A 1 form4a.xml PRIMARY DOCUMENT X0303 4/A 2008-12-03 2008-12-04 0000318154 AMGEN INC AMGN 0001183903 BONANNI FABRIZIO ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 EVP, Operations Common Stock 2008-12-03 4 S 0 32393 56.0549 D 12000 D Common Stock 2008-12-03 4 M 0 32393 38.36 A 44393 D Common Stock 60095 I By Family Trust Nqso (Right to Buy) 38.36 2008-12-03 4 M 0 32393 0 D 2003-07-01 2009-07-01 Common Stock 32393 0 D This option was exercisable in four annual installments commencing July 1, 2003 and is now fully exercisable. This amendment amends the number of shares sold which was originally reported as 32.393. The sale price is an average sale price with a low of $56.04 per share and a high of $56.08 per share. A detailed list of the number of shares sold and the sale price of each share is available upon request by the SEC staff, the issuer of a security holder of the issuer. Represents Restricted Stock Units (RSUs) granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest in four equal annual installments of 25% each commencing on April 29, 2009. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the executive officer. /s/ Fabrizio Bonanni 2009-01-08 -----END PRIVACY-ENHANCED MESSAGE-----